Report
Merck discontinues antibiotic Recarbrio in the U.S.
STAT says the move underscores concerns about large drugmakers’ commitment to antibiotics, a field crucial to public health.
TLDR
STAT reports that Merck discontinued Recarbrio, which it describes as an important antibiotic, from the U.S. market. The outlet says the move underscores concerns about large pharmaceutical companies’ commitment to antibiotics, alongside concerns about superbug resistance.
Combined views
1.4K
1 Source, first seen 4h ago
likes